JD’s manually curated links for God-fearing MAGA patriots
In this WND article, Will Coggin argues that America’s dependence on China for critical pharmaceutical ingredients is not merely an economic weakness but a serious national security vulnerability.
- The article warns that China is tightening controls on American investment in strategic sectors, a move that should remind Washington to protect its own critical industries.
- Coggin argues that few sectors matter more to national security than health care, especially since more than 131 million Americans use prescription medications.
- The central concern is America’s reliance on foreign pharmaceutical supply chains, particularly China’s role in producing Active Pharmaceutical Ingredients used in common medicines.
- The pandemic exposed how dangerous foreign dependence can be when U.S. leaders scrambled to secure masks, gloves, and other medical supplies from overseas.
- The article says Beijing has already shown a willingness to weaponize supply chains, including through its leverage over rare earth minerals.
- Coggin warns that China’s centralized industrial planning is now expanding into biotechnology and frontier science, potentially giving Beijing more control over future medical breakthroughs.
- The piece argues that America’s free-market system is a key advantage over China, but Congress must create the right incentives to expand domestic pharmaceutical production.
- Recent tax reforms and President Trump’s 2025 order to streamline drug-production approvals are presented as positive steps, though the article says Congress should codify those reforms.
- The article points to Indiana, North Carolina, and Puerto Rico as existing pharmaceutical production hubs that could be strengthened to reduce reliance on China.
- Coggin concludes that securing America’s medicine supply chain is both sound economic policy and a national security imperative.
Read the full story: https://www.wnd.com/2026/05/its-not-theoretical-americas-medicine-supply-chain-is/


